Tantalus Labs is a brand owned by Atlantic Cultivation, and previously was a Canadian Licensed Producer of cannabis. Originally based out of British Columbia and established in 2012 by Dan Sutton, Tantalus Labs cultivated in their cannabis greenhouse, SunLab which was the first purpose-built cannabis greenhouse in North America. In June 2023, Tantalus Labs announced it would cease operations and began laying off the majority of its employees. [1] [2]
Tantalus Labs was founded by Dan Sutton and incorporated on October 29, 2012. Having seen a consultation document outlining the Marijuana for Medical Purposes Regulation (MMPR), he recognized the opportunity to rethink how cannabis was being grown in BC and engaged agricultural experts to design a more efficient methodology. The result was the planning and design of SunLab, the first purpose-built cannabis cultivation facility in North America.
On May 29, 2017, Health Canada approved the company's submission for a Medical Marijuana License allowing them to acquire materials and commence planting seed crops, making them the 45th Licensed Producer in Canada and the 10th in British Columbia. [3]
August 17, 2018, the company announced it had received its sales license from Health Canada, allowing it to begin on-boarding patients and ship cannabis products. [4]
September 12, 2018, Tantalus Labs launched Tantalus Prime, its e-commerce membership program that provides door-to-door delivery directly from SunLab to registered customers. The five inaugural strains includes Blue Dream, Serratus, Skunk Haze, Harlequin, and Cannatonic. [5]
In June 2023, Tantalus Labs announced that it would cease operations and began laying off the majority of its employees. [1] [2]
On May 22, 2015, prior to receiving their Medical Marijuana License, 150 residents of Maple Ridge protested the development of SunLab stating concerns around well water depletion and proximity to residential neighbourhoods. [6] In response, Tantalus Labs licensed their well access with the BC Ministry of Forestry and committed to rainwater as its primary water source for irrigation.
Executive Dan Sutton has identified the carbon footprint associated with modern indoor growing techniques that rivals heavy industrial manufacturing. [7]
Tantalus Labs and Hanway Associates produced and shared a policy guidance document with 19 BC Ministries and representatives on September 18, 2017. This document provided context and recommendations around the legal age of consumption, Retail Licensing, Supply Chain Management, Transparency and Reporting, and Ancillary Industries. Receiving no response, Tantalus Labs published this document so that the citizens of British Columbia can hold elected officials to their obligation to foster the cannabis industry and its impactful cultural history. This was the second policy guidance document produced in collaboration with Hanway Associates. [8] [9]
Marc Scott Emery is a Canadian cannabis rights activist, entrepreneur and politician. Often described as the "Prince of Pot", Emery has been a notable advocate of international cannabis policy reform, and has been active in multiple Canadian political parties at the provincial and federal levels. Emery has been jailed several times for his cannabis activism.
Cannabis in British Columbia (BC) relates to a number of legislative, legal, and cultural events surrounding the use and cultivation of cannabis in the Canadian province of British Columbia. As with the rest of Canada, cannabis became legalized on 17 October 2018, following the enactment of the Cannabis Act, or Bill C-45. Prior to that, though the drug was illegal in Canada, its recreational use was often tolerated and was more commonplace in the province of BC as compared to most of the rest of the country. The province's inexpensive hydroelectric power and abundance of water and sunshine—in addition to the many hills and forests —made it an ideal cannabis growing area. The British Columbia cannabis industry is worth an estimated CA$2 billion annually and produces 36.6 percent of all Canadian cannabis. The province is also the home of the cannabis activist and businessman Marc Emery.
Oregon Ballot Measure 80, also known as the Oregon Cannabis Tax Act, OCTA and Initiative-9, was an initiated state statute ballot measure on the November 6, 2012 general election ballot in Oregon. It would have allowed personal marijuana and hemp cultivation or use without a license and created a commission to regulate the sale of commercial marijuana. The act would also have set aside two percent of profits from cannabis sales to promote industrial hemp, biodiesel, fiber, protein, and oil.
MedMen Enterprises was a United States-based cannabis company. At its peak, it had operations in California, Nevada, Arizona, Florida, Illinois, New York, and Massachusetts. MedMen owns and operates 29 retail stores and 6 cultivation facilities and is currently licensed to expand its footprint to 65 retail locations. Its stock trades on the Canadian Securities Exchange under the ticker symbol MMEN. MedMen is also traded over-the-counter in the United States under the ticker symbol MMNFF. MedMen is based in Culver City, California and has more than 1,000 employees.
Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a cannabis company based in Smiths Falls, Ontario.
Cannabis in Nevada became legal for recreational use on January 1, 2017, following the passage of Question 2 on the 2016 ballot with 54% of the vote. The first licensed sales of recreational cannabis began on July 1, 2017.
Cannabis in Missouri is legal for recreational use. A ballot initiative to legalize recreational use, Amendment 3, passed by a 53–47 margin on November 8, 2022. Possession for adults 21 and over became legal on December 8, 2022, with the first licensed sales occurring on February 3, 2023.
Cannabis in Ohio is legal for recreational use. Issue 2, a ballot measure to legalize recreational use, passed by a 57–43 margin on November 7, 2023. Possession and personal cultivation of cannabis became legal on December 7, 2023, with the first licensed sales yet to occur under the law. Prior to legalization, Ohio decriminalized possession of up 100 grams in 1975, with several of the state's major cities later enacting further reforms.
The list includes and details significant events that occurred in the global history of national-level implementations of, or changes made to, laws surrounding the use, sale, or production of the psychoactive drug cannabis.
Cannabis in Lesotho is illegal for any use, but largely tolerated. Cannabis is widely produced in the country, being the nation's most significant cash-crop. In the 2000s it was estimated that 70% of the cannabis in South Africa originated in Lesotho. In 2017 Lesotho became the first African nation to grant a license for the cultivation of medical cannabis.
The Cannabis Act (C-45) of June, 2018 paved the way for the legalization of cannabis in Canada on 17 October 2018. Police and prosecution services in all Canadian jurisdictions are currently capable of pursuing criminal charges for cannabis marketing without a licence issued by Health Canada. The Supreme Court of Canada has held that the federal Parliament has the power to criminalize the possession of cannabis and that doing so does not infringe upon the Canadian Charter of Rights and Freedoms. The Ontario Court of Appeal and the Superior Court of Ontario have, however, held that the absence of a statutory provision for medical marijuana is unconstitutional, and to that extent the federal law is of no force and/or effect if a prescription is obtained. The recreational use of cannabis has been legalized by the federal government, and took effect on 17 October 2018.
On October 17, 2018, cannabis was legalized in Canada for recreational and medical purposes. It was already legal for medicinal purposes, under conditions outlined in the Marihuana for Medical Purposes Regulations issued by Health Canada, and for seed, grain, and fibre production under licence by Health Canada.
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of late September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB.
Tweed Farms in Niagara-on-the-Lake, Ontario was the world's largest legal cannabis greenhouse in 2014. At that time, it had 350,000 square feet (33,000 m2) of indoor space. It is owned by Canopy Growth Corporation, a publicly traded Canadian company. In 2017 the company received a license to expand to c. 1,000,000 square feet (93,000 m2) of space, to be ready for production by April 2018.
Delta 3 greenhouse in East Ladner, southwest British Columbia, may be the world's largest cannabis greenhouse. As of 2018, the greenhouse is owned by Pure Sunfarms, a wholly owned subsidiary of Village Farms International. In early 2018, it was licensed to expand to 1,100,000 square feet (100,000 m2) (25 acres), enough to produce 75 metric tons of cannabis annually. The company owning the greenhouse has options to expand to another two greenhouses; combined they would produce 300 metric tons per year, equal to roughly half of Canada's entire recreational cannabis consumption at the time nationwide legalization commenced in 2018.
A budtender is a title of a staff member who works within a dispensary or store where medical or recreational cannabis is sold. Their job is to offer suggestions to customers, answer questions, handle products and showcase products being sold.
VIVO Cannabis Inc(formerly ABcann Global) is a Canadian licensed cannabis producer, headquartered in Napanee, Ontario. Prior to being acquired by MediPharm Labs Corp., VIVO traded on the Toronto Stock Exchange as VIVO.
Zenabis Global Inc. was a Canadian medical and recreational marijuana producer.
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use. The company's stock trades on the Canadian Securities Exchange under the ticker symbol CL, and in over-the-counter markets in the United States with the ticker symbol CRLBF.